JP2013107903A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013107903A5 JP2013107903A5 JP2013045053A JP2013045053A JP2013107903A5 JP 2013107903 A5 JP2013107903 A5 JP 2013107903A5 JP 2013045053 A JP2013045053 A JP 2013045053A JP 2013045053 A JP2013045053 A JP 2013045053A JP 2013107903 A5 JP2013107903 A5 JP 2013107903A5
- Authority
- JP
- Japan
- Prior art keywords
- bis
- composition
- phenylene
- methylene
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70997805P | 2005-08-19 | 2005-08-19 | |
| US60/709,978 | 2005-08-19 | ||
| US73473605P | 2005-11-08 | 2005-11-08 | |
| US60/734,736 | 2005-11-08 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008527219A Division JP2009504788A (ja) | 2005-08-19 | 2006-08-21 | 化学療法の強化方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013169087A Division JP2013231086A (ja) | 2005-08-19 | 2013-08-16 | 化学療法の強化方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013107903A JP2013107903A (ja) | 2013-06-06 |
| JP2013107903A5 true JP2013107903A5 (OSRAM) | 2013-10-03 |
Family
ID=37758501
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008527219A Pending JP2009504788A (ja) | 2005-08-19 | 2006-08-21 | 化学療法の強化方法 |
| JP2013045053A Pending JP2013107903A (ja) | 2005-08-19 | 2013-03-07 | 化学療法の強化方法 |
| JP2013169087A Pending JP2013231086A (ja) | 2005-08-19 | 2013-08-16 | 化学療法の強化方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008527219A Pending JP2009504788A (ja) | 2005-08-19 | 2006-08-21 | 化学療法の強化方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013169087A Pending JP2013231086A (ja) | 2005-08-19 | 2013-08-16 | 化学療法の強化方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070043012A1 (OSRAM) |
| EP (1) | EP1951046B1 (OSRAM) |
| JP (3) | JP2009504788A (OSRAM) |
| CN (1) | CN101365336B (OSRAM) |
| AU (1) | AU2006280945A1 (OSRAM) |
| BR (1) | BRPI0615180A2 (OSRAM) |
| CA (1) | CA2619828A1 (OSRAM) |
| IL (1) | IL189599A0 (OSRAM) |
| WO (1) | WO2007022523A2 (OSRAM) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10149889B2 (en) * | 2005-11-25 | 2018-12-11 | Rutgers, The State University Of New Jersey | Compositions for the treatment of cancer, and methods for testing and using the same |
| US8926990B2 (en) | 2009-10-13 | 2015-01-06 | Rutgers, The State University Of New Jersey | Treatment and diagnosis of inflammatory disorders and HIV |
| WO2008075370A2 (en) * | 2006-12-21 | 2008-06-26 | Biokine Therapeutics Ltd. | T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy |
| WO2008109076A1 (en) * | 2007-03-02 | 2008-09-12 | Oxigene, Inc. | Methods for enhancing the efficacy of vascular disrupting agents |
| JP2012516353A (ja) * | 2009-01-30 | 2012-07-19 | ジェンザイム・コーポレーション | 血液系悪性腫瘍を治療するための方法及び組成物 |
| US9427456B2 (en) | 2009-06-14 | 2016-08-30 | Biokine Therapeutics Ltd. | Peptide therapy for increasing platelet levels |
| US20110207814A1 (en) * | 2009-12-23 | 2011-08-25 | Pranela Rameshwar | Combination Therapy for Breast Cancer Treatment |
| CN103108641B (zh) * | 2010-09-09 | 2016-01-13 | 诺松制药股份公司 | Sdf-1结合性核酸及其在癌症治疗中的用途 |
| US20150030561A1 (en) | 2011-05-16 | 2015-01-29 | Genzyme Corp. | Use of CXCR4 Antagonists |
| WO2013160895A1 (en) | 2012-04-24 | 2013-10-31 | Biokine Therapeutics Ltd. | Peptides and use thereof in the treatment of large cell lung cancer |
| MX363896B (es) | 2013-03-24 | 2019-04-05 | Biokine Therapeutics Ltd | Combinación de un antagonista de cxcr4y y citarabina para el uso en el tratamiento de leucemia mieloide. |
| US20160243187A1 (en) | 2013-10-31 | 2016-08-25 | Biokine Therapeutics Ltd. | Methods of treating acute myeloid leukemia with a flt3 mutation |
| KR20160132031A (ko) * | 2014-02-19 | 2016-11-16 | 마이크로콘스탄스 차이나 아이엔씨 | 케모카인 수용체 대항물질 및 그것의 병용 요법 |
| WO2016114634A2 (ko) * | 2015-01-16 | 2016-07-21 | 서울대학교 산학협력단 | 사이클램 유도체 화합물 및 이의 약학적 용도 |
| KR101759688B1 (ko) * | 2015-01-16 | 2017-07-20 | 서울대학교산학협력단 | 사이클램 유도체 화합물 및 이의 약학적 용도 |
| JP2018513201A (ja) | 2015-04-25 | 2018-05-24 | ザ ジェネラル ホスピタル コーポレイション | 抗ｆｕｇｅｔａｃｔｉｃ剤と抗癌剤の併用療法、および、癌の治療のための組成物 |
| CA3026154A1 (en) | 2015-06-03 | 2016-12-08 | The University Of Queensland | Mobilizing agents and uses therefor |
| EP3744340A3 (en) | 2015-07-16 | 2021-03-03 | Biokine Therapeutics Ltd. | Compositions and methods for treating cancer |
| AU2016324303A1 (en) * | 2015-09-18 | 2018-04-26 | The General Hospital Corporation Dba Massachusetts General Hospital | Modified T-cells having anti-fugetactic properties and uses thereof |
| ES2907489T3 (es) * | 2015-12-14 | 2022-04-25 | X4 Pharmaceuticals Inc | Métodos para el tratamiento del cáncer |
| WO2017106332A1 (en) | 2015-12-14 | 2017-06-22 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| US10993985B2 (en) | 2016-02-23 | 2021-05-04 | BioLmeRx Ltd. | Methods of treating acute myeloid leukemia |
| WO2017177230A1 (en) | 2016-04-08 | 2017-10-12 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| CA3027500A1 (en) | 2016-06-21 | 2017-12-28 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
| WO2017223229A1 (en) | 2016-06-21 | 2017-12-28 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
| JP7054529B2 (ja) | 2016-06-21 | 2022-04-14 | エックス４ ファーマシューティカルズ， インコーポレイテッド | Ｃｘｃｒ４阻害剤およびその使用 |
| JP2020525427A (ja) * | 2017-06-21 | 2020-08-27 | エックス４ ファーマシューティカルズ， インコーポレイテッド | 癌を処置するための方法 |
| US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
| EP3856225A1 (en) | 2018-09-25 | 2021-08-04 | BioLineRx Ltd. | Methods of selecting treatment for cxcr4-associated cancer |
| JP2023517956A (ja) | 2020-03-10 | 2023-04-27 | エックス４ ファーマシューティカルズ， インコーポレイテッド | 好中球減少症を処置する方法 |
| TWI781469B (zh) * | 2020-10-27 | 2022-10-21 | 行政院原子能委員會核能研究所 | 複合物、造影劑及治療與cxcr4接受體相關疾病的用途 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4005204A (en) * | 1973-03-23 | 1977-01-25 | Burroughs Wellcome Co. | Treatment of neoplasms in the brain with diamino dichloroalkyl pyrimidine |
| US6001826A (en) | 1989-12-21 | 1999-12-14 | Anormed, Inc. | Chemical compounds |
| US5021409A (en) * | 1989-12-21 | 1991-06-04 | Johnson Matthey Plc | Antiviral cyclic polyamines |
| GB9105489D0 (en) | 1991-03-15 | 1991-05-01 | Johnson Matthey Plc | Improvements in chemical compounds |
| GB9126677D0 (en) | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| GB9400411D0 (en) | 1994-01-11 | 1994-03-09 | Johnson Matthey Plc | Improvements in chemical compounds |
| GB9511357D0 (en) | 1995-06-06 | 1995-08-02 | Johnson Matthey Plc | Improved antiviral compounds |
| US6506770B1 (en) | 1996-06-06 | 2003-01-14 | Anormed, Inc. | Antiviral compounds |
| CA2305787A1 (en) * | 2000-05-09 | 2001-11-09 | The University Of British Columbia | Cxcr4 antagonist treatment of hematopoietic cells |
| AP1654A (en) | 1999-03-24 | 2006-09-01 | Anormed Inc | Chemokine receptor binding heterocyclic compounds. |
| WO2001044229A1 (en) * | 1999-12-17 | 2001-06-21 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds |
| MXPA03002325A (es) | 2000-09-15 | 2003-06-24 | Anormed Inc | Compuestos heterociclicos que se unen a receptor de quimiocina. |
| DK1317451T3 (da) | 2000-09-15 | 2006-12-18 | Anormed Inc | Kemokinreceptorbindende heterocykliske forbindelser |
| US6864265B2 (en) | 2000-09-15 | 2005-03-08 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| WO2002053138A2 (en) * | 2001-01-02 | 2002-07-11 | Elisabeth Shanahan-Prendergast | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| MXPA03006542A (es) | 2001-01-23 | 2003-09-22 | P & G Clairol Inc | Intermediarios primarios para la coloracion oxidativa del cabello. |
| JP5137288B2 (ja) * | 2001-07-31 | 2013-02-06 | アノーメッド インコーポレイティド | 前駆／幹細胞を動員する方法 |
| US7169750B2 (en) * | 2001-07-31 | 2007-01-30 | Anormed, Inc. | Methods to mobilize progenitor/stem cells |
| CN1596255A (zh) | 2001-12-21 | 2005-03-16 | 阿诺麦德股份有限公司 | 具有强效的与趋化因子受体结合的杂环化合物 |
| JP2006524242A (ja) * | 2003-03-27 | 2006-10-26 | エモリー ユニバーシティー | Ｃｘｃｒ４アンタゴニストおよびそれらの使用方法 |
| US20040202935A1 (en) | 2003-04-08 | 2004-10-14 | Jeremy Barker | Cathode active material with increased alkali/metal content and method of making same |
| CA2520259A1 (en) | 2003-04-11 | 2004-10-28 | Anormed Inc. | Cxcr4 chemokine receptor binding compounds |
| ES2368741T3 (es) * | 2004-02-25 | 2011-11-21 | Dana-Farber Cancer Institute, Inc. | Inhibidores del receptor 1 del factor de crecimiento de tipo insulina para inhibir el crecimiento de células tumorales. |
| EP1796716A4 (en) * | 2004-08-13 | 2010-09-08 | Anormed Inc | COMBINATIONS OF CHEMOKINES FOR MOBILIZING PROGENITOR / STEM CELLS |
| US7825088B2 (en) * | 2005-04-25 | 2010-11-02 | The Cbr Institute For Biomedical Research, Inc. | Methods for the treatment of multiple myeloma |
| US8569280B2 (en) * | 2005-04-25 | 2013-10-29 | Immune Disease Institute | Methods for the treatment of multiple myeloma |
| AU2006340074A1 (en) * | 2006-02-24 | 2007-09-20 | Genzyme Corporation | Methods for increasing blood flow and/or promoting tissue regeneration |
-
2006
- 2006-08-21 CA CA002619828A patent/CA2619828A1/en not_active Abandoned
- 2006-08-21 EP EP06813613A patent/EP1951046B1/en not_active Revoked
- 2006-08-21 WO PCT/US2006/032668 patent/WO2007022523A2/en not_active Ceased
- 2006-08-21 AU AU2006280945A patent/AU2006280945A1/en not_active Abandoned
- 2006-08-21 BR BRPI0615180-9A patent/BRPI0615180A2/pt not_active IP Right Cessation
- 2006-08-21 CN CN2006800350846A patent/CN101365336B/zh not_active Expired - Fee Related
- 2006-08-21 JP JP2008527219A patent/JP2009504788A/ja active Pending
- 2006-08-21 US US11/507,717 patent/US20070043012A1/en not_active Abandoned
-
2008
- 2008-02-18 IL IL189599A patent/IL189599A0/en unknown
-
2013
- 2013-03-07 JP JP2013045053A patent/JP2013107903A/ja active Pending
- 2013-08-16 JP JP2013169087A patent/JP2013231086A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2757373C2 (ru) | Комбинированная терапия противоопухолевым алкалоидом | |
| JP7025416B2 (ja) | 好中球減少症を低減させるための組成物および方法 | |
| JP2013107903A (ja) | 化学療法の強化方法 | |
| JP2022520061A5 (OSRAM) | ||
| ME02470B (me) | Nanočesтice nabijene sa hemoterapeutskim anтitumorskim lekom | |
| JP2020097577A5 (OSRAM) | ||
| JP2013507439A5 (OSRAM) | ||
| JP2019511565A (ja) | ツカレゾールまたはそのアナログを含む組成物 | |
| JP2016534142A5 (OSRAM) | ||
| US20220047507A1 (en) | Melflufen dosage regimens for cancer | |
| WO2011159100A2 (ko) | 항암 활성을 나타내는 약제학적 조성물 | |
| JP2012502915A5 (OSRAM) | ||
| JP2014521641A5 (OSRAM) | ||
| JP2016515550A5 (OSRAM) | ||
| JP2014148552A5 (OSRAM) | ||
| WO2007108272A1 (ja) | 癌治療用キットおよび癌治療用医薬組成物 | |
| SI2847204T1 (en) | Sterol derivatives and their use for the treatment of diseases involving the transformation of astrocytic cells or the treatment of malignant haemopathies | |
| JP2016501208A5 (OSRAM) | ||
| HRP20191322T1 (hr) | Antitumorska kombinacija koja sadži kabazitaksel i cisplatin | |
| RU2017125150A (ru) | Фармацевтическая композиция для лечения или создания условий ремиссии у пожилого пациента с раком или у пациента на терминальной стадии рака | |
| CN103417977A (zh) | 叶酸受体α亚型高效介导的靶向投药系统 | |
| KR20090103899A (ko) | 백혈병을 치료하기 위한 신규한 치료 용도 | |
| JP2020528418A (ja) | ＢＥＴ阻害剤及びＢｃｌ−２阻害剤を用いた併用療法 | |
| EP2826482A1 (en) | Novel antitumor agent comprising combination of three agents | |
| JP2019525924A5 (OSRAM) |